The trusted source for
healthcare information and
Vaping associated lung injury (VALI) has risen as an epidemic in the United States and has received much media attention. VALI encompasses a spectrum of inhalation injuries that present with variable clinical features. VALI is an epidemic that has received much media attention. Providers have variable knowledge on VALI. It is extremely important to standardize the approach to patient with suspected VALI in order to optimize patient outcomes and decrease morbidity and mortality.
Dr. Daniel Migliaccio has no relevant financial or nonfinancial relationships to disclose that is related to this educational activity.The planners of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.
ANCC: Relias LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Contact hours [1.0] will be awarded to participants who meet the criteria for successful completion. California Board of Registered Nursing, Provider CEP#13791.
ACCME: Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Relias LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CE activity available for streaming on April 6th, 2020
This CE activity is valid until April 6th, 2023